Objective: The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011. Methods: State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot. Results: The global coverage rates, 3years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine. Conclusion: This study shows that it is possible to obtain a good coverage rates after 3years of a state-coordinated HPV vaccination progra
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomav...
Abstract Background Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, ...
Background: Human papillomavirus (HPV) is a sexually transmitted infection that can lead to cancers ...
ABSTRACT Objective: The objective of this study is to assess the HPV vaccination coverage of 11 to 1...
The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during...
We describe a human papillomavirus (HPV) vaccination program implemented since 2007 in Geneva Canton...
OBJECTIVES: Human papillomavirus (HPV) is a sexually transmitted infection of particular interest be...
Objectives: Human papillomavirus (HPV) is a sexually transmitted infection of particular interest be...
OBJECTIVES The objectives were to measure uptake of and factors associated with human papillomavi...
Since 2007, the Standing Committee on Vaccination (STIKO) has recommended that all girls receive vac...
Background: The human papillomavirus (HPV) vaccination program for young girls aged 11⁻26 years was ...
Since 2007, the Standing Committee on Vaccination (STIKO) has recommended that all girls receive vac...
Background: The human papillomavirus (HPV) vaccination program for young girls aged 11⁻26 years was ...
Switzerland, with an adolescent HPV vaccination coverage at 59%, remains far from reaching the cruci...
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomav...
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomav...
Abstract Background Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, ...
Background: Human papillomavirus (HPV) is a sexually transmitted infection that can lead to cancers ...
ABSTRACT Objective: The objective of this study is to assess the HPV vaccination coverage of 11 to 1...
The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during...
We describe a human papillomavirus (HPV) vaccination program implemented since 2007 in Geneva Canton...
OBJECTIVES: Human papillomavirus (HPV) is a sexually transmitted infection of particular interest be...
Objectives: Human papillomavirus (HPV) is a sexually transmitted infection of particular interest be...
OBJECTIVES The objectives were to measure uptake of and factors associated with human papillomavi...
Since 2007, the Standing Committee on Vaccination (STIKO) has recommended that all girls receive vac...
Background: The human papillomavirus (HPV) vaccination program for young girls aged 11⁻26 years was ...
Since 2007, the Standing Committee on Vaccination (STIKO) has recommended that all girls receive vac...
Background: The human papillomavirus (HPV) vaccination program for young girls aged 11⁻26 years was ...
Switzerland, with an adolescent HPV vaccination coverage at 59%, remains far from reaching the cruci...
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomav...
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomav...
Abstract Background Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, ...
Background: Human papillomavirus (HPV) is a sexually transmitted infection that can lead to cancers ...